Corporate News     28-May-22
Board of Astrazeneca Pharma India recommends Final Dividend
Of Rs.4 per share
Astrazeneca Pharma India announced that the Board of Directors of the Company at its meeting held on 27 May 2022, has recommended a Final dividend of Rs.8 per share (i.e.400%), subject to the approval of the shareholders.
Previous News
  AstraZeneca receives import and market permission for Acalabrutinib 100mg capsules
 ( Corporate News - 13-Mar-20   10:07 )
  Astrazeneca Pharma India to hold board meeting
 ( Corporate News - 19-May-21   09:45 )
  AstraZeneca Pharma receives DCGI approval for launch of Benralizumab (Fasenraâ„¢) in India
 ( Corporate News - 21-Dec-20   08:55 )
  Astrazeneca Pharma India to announce Quarterly Result
 ( Corporate News - 24-Jan-19   17:22 )
  Volumes spurt at Godrej Industries Ltd counter
 ( Hot Pursuit - 27-May-22   14:30 )
  Board of Astrazeneca Pharma India appoints director
 ( Corporate News - 15-Mar-19   13:04 )
  Board of Astrazeneca Pharma India appoints director
 ( Corporate News - 15-Mar-19   10:02 )
  Astrazeneca Pharma India standalone net profit rises 57.94% in the September 2019 quarter
 ( Results - Announcements 11-Nov-19   16:51 )
  Astrazeneca Pharma tumbles after board defers delisting offer
 ( Hot Pursuit - 06-Mar-14   09:37 )
  Astrazeneca Pharma India reports net loss of Rs 8.15 crore in the June 2012 quarter
 ( Results - Announcements 10-Aug-12   18:23 )
  Astrazeneca Pharma India to convene board meeting
 ( Corporate News - 13-May-20   09:10 )
Other Stories
  GRP schedules AGM
  01-Jul-24   20:01
  Mahindra & Mahindra domestic PV sales jump 23% in June
  01-Jul-24   20:01
  Vipul Organics constructs new factory in Ambernath, Maharashtra
  01-Jul-24   20:00
  Greaves Engineering launches range of new CPCB IV+ Compliant Gensets
  01-Jul-24   19:41
  Godrej Properties to develop 7-acre land in Thanisandra, North Bengaluru
  01-Jul-24   19:39
  Rama Phosphates AGM scheduled
  01-Jul-24   19:34
  Take Solutions to convene AGM
  01-Jul-24   19:34
  Fischer Medical Ventures partners with Singapore-based Nervotec
  01-Jul-24   19:29
  NIIT appoints Pankaj Jathar as Chief Executive Officer
  01-Jul-24   19:27
  Dynacons Systems recognized as India's Leading Listed ESG Entities 2024
  01-Jul-24   19:26
Back Top